Sustainability Day: It’s not just for the last Wednesday in October 

Posted on by Karen Burkhartzmeyer

Happy Sustainability Day! You may not realize that the last Wednesday of every October is dedicated to reminding us of the importance of caring for our planet. Maybe you rode your bike to work today, replaced a burned-out lightbulb with an efficient LED bulb or made sure to turn off the water while brushing your teeth. (You won’t believe how much water this simple act will save. My fifth-grade teacher imparted this wisdom to me many, many, many years ago.)  

We do our best to live our values here at Promega and we like to think that every day is one to prioritize and practice sustainable living. Like so many others, we are certainly learning along the way, and have a long way to go. But we were excited to announce this summer that Promega now draws over 20% of our global electricity from renewable sources. Investments in solar arrays have led to a ten-fold increase in renewable energy usage in the last three years.  

Reducing Electricity Usage

Minimizing electricity usage at all our branches, distribution and manufacturing locations around the world is a priority since Promega has a goal to reduce carbon emissions by 50% as indexed to revenue by 2030. Electricity makes up nearly half of Promega emissions, so we are doing what we can to lessen this impact. 

Continue reading “Sustainability Day: It’s not just for the last Wednesday in October “

Unearthing History: How Forensic Analysis of a Racial Massacre is Bringing Closure to a Community 100 Years Later

Posted on by Jordan Nutting

This article was originally published in the May 2022 issue of the ISHI Report.

On October 19, 2020, in a corner of what was once the African American section of the Potter’s Field in Tulsa’s Oaklawn Cemetery, a backhoe begins scraping away layer after layer of red Oklahoma earth. Workers in high-visibility vests and orange hard hats prepare to join the excavation. DeNeen Brown, a reporter with the Washington Post, looks on, bearing witness to a site that could be one of the final, unmarked resting places for victims of a massacre that happened 100 years in the past.

A mural painted on a building's brick wall is a colorful patchwork of portraits and historic Tulsa scenes.
“History in the Making”, a wall painting in the Greenwood District of Tulsa, Oklahoma by artist Skip Hill depicts residents of the district known as the “Black Wall Street”. Photo Credit: Tara Luther.
Continue reading “Unearthing History: How Forensic Analysis of a Racial Massacre is Bringing Closure to a Community 100 Years Later”

Neanderthal DNA and Modern Humans: Svante Pääbo Receives the 2022 Nobel Prize in Physiology or Medicine

Posted on by Ken Doyle

What makes humans “human”?

Neanderthal DNA sequencing from ancient bone samples

On October 3, 2022, the Nobel Assembly at Karolinska Institutet announced the 2022 Nobel Prize in Physiology or Medicine had been awarded to Svante Pääbo, director of the Department of Genetics at the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany. The Assembly cited his “discoveries concerning the genomes of extinct hominins and human evolution”. They mentioned the highlight of his research: the seemingly impossible task, at the time, of sequencing the Neanderthal genome. The discoveries that followed from this sequencing project continue to redefine our understanding of modern human origins.

The award showcases the technological advancements made in the analysis of ancient DNA. However, Pääbo’s research had an inauspicious beginning. In 1985, he published the results of his early work, cloning and sequencing DNA fragments from a 2,400-year-old Egyptian mummy (1). Unfortunately, later analysis revealed that the samples could have been contaminated by the researchers’ own DNA (2).

Continue reading “Neanderthal DNA and Modern Humans: Svante Pääbo Receives the 2022 Nobel Prize in Physiology or Medicine”

Inside the First Promega Targeted Protein Degradation Symposium

Posted on by Jordan Villanueva
Poster session at the Targeted Protein Degradation Symposium
Researchers attend a poster session at the first Targeted Protein Degradation Symposium

On September 20, more than 60 scientists from across North America convened at Promega Madison for our first Targeted Protein Degradation Symposium. For two days, speakers shared their most recent advances in this exciting field.

“What has really stood out for me is the collective energy, the openness, the willingness of people to share their struggles, their successes, their compound structures, and really embody this broader goal of working together to build capabilities that will ultimately lead to successful therapeutic compounds,” says Promega Senior Research Scientist Kristin Riching.

Continue reading “Inside the First Promega Targeted Protein Degradation Symposium”

What Have You Done for Your Emotional Wellness, This Month? 

Posted on by Riley Bell

Most of us are familiar with the term wellness. We associate wellness with lifestyle practices such as exercising, having a balanced diet, and taking care of our bodies. As significant as these practices are to live long, healthy lives, there’s a critical component of wellness that is often overlooked, emotional wellness. 

The National Center for Emotional Wellness defines emotional wellness as, “An awareness, understanding and acceptance of our feelings, and our ability to effectively manage through challenges and change.” Maintaining a healthy emotional balance helps us form better relationships with peers, make healthier lifestyle choices, and empower people through life’s unexpected changes. October, Emotional Wellness Month, is the perfect reminder to take time out for your brain and make steps towards effectively managing your emotions.

Continue reading “What Have You Done for Your Emotional Wellness, This Month? “

Circulating Nucleic Acids in Human Biofluids and Liquid Biopsy Research

Posted on by Douglas Horejsh

Several different types of nucleic acids can be found circulating in human biofluids. Fragmented DNA and RNA are now routinely purified from plasma and other bodily fluids. These types of nucleic acids need to be purified from a cell-free fraction of the biofluids to ensure that the isolated nucleic acids are truly circulating and not from intact cells. In this blog post, we will learn a bit more about circulating nucleic acids (CNA) and how they can be used as biomarkers in research.

Continue reading “Circulating Nucleic Acids in Human Biofluids and Liquid Biopsy Research”

“Forever” Chemicals: Forever No More

Posted on by Jordan Nutting

If you were tasked with destroying something called “forever chemicals”, chances are you’d be leaning towards rather harsh methods. Incineration would probably be on the table.

These so-called “forever chemicals”, or per- and polyfluoroalkyl substances (PFAS), are a family of organic compounds where fluoride replaces hydrogens atoms on carbon chains. They are very water and oil repellent, which makes them ideal for use in non-stick cookware, stain-proof fabrics and fire-suppressing foams. Recent studies, however, show that exposure to PFAS is linked to a range of health issues—from increased cholesterol levels to some cancers. Even levels of PFAS present in drinking water in as low as parts per billion levels can pose risks to human health. These risks are exacerbated by the tendency for PFAS to bioaccumulate, or become concentrated in the tissues of humans and animals.

Methods do exist to filter out PFAS from water. But what do you do when it’s time to replace those filters? Simply throwing out PFAS-contaminated equipment just moves the problem to a landfill.

Person getting a glass of water from a kitchen faucet.

Instead, these “forever chemicals” need to be destroyed. Most existing strategies for breaking down PFAS use harsh conditions, such as incinerating PFAS residues in furnaces or oxidizing them in supercritical water—water that is at more than 37°C and 200atm of pressure. Now, scientists reporting in Science have discovered that such extreme methods may not be needed to destroy “forever chemicals” (1).

Continue reading ““Forever” Chemicals: Forever No More”

mRNA Vaccine Manufacturing: Responding Effectively to a Global Pandemic

Posted on by Ken Doyle

We’ve learned a few important lessons from the COVID-19 pandemic.

Perhaps the most significant one is the importance of an early and rapid global response to the initial outbreak. A coordinated response—including widespread use of masks and other personal protective equipment (PPE), travel restrictions, lockdowns and social distancing—could save lives and reduce long-term health effects (1). Widespread availability of effective vaccines goes hand in hand with these measures.

New Boosters to Fight Omicron

Last month, Pfizer/BioNTech announced the US Food and Drug Administration (FDA) had granted emergency use authorization (EUA) for a new adapted-bivalent COVID-19 booster vaccine for individuals 12 years and older. This vaccine combines mRNA encoding the wild-type Spike protein from the original vaccine with another mRNA encoding the Spike protein of the Omicron BA.4/BA.5 subvariants. Moderna also announced FDA EUA for its new Omicron-targeting COVID-19 booster vaccine. The Omicron variant of SARS-CoV-2 shows multiple mutations across its subvariants, and it is currently the dominant SARS-CoV-2 variant of concern across the world.

Genomic epidemiology of SARS-CoV-2 with subsampling focused globally over the past 6 months. This phylogenetic tree shows evolutionary relationships of SARS-CoV-2 viruses from the ongoing COVID-19 pandemic. Image from Nextstrain.org; generated September 20, 2022

Booster doses of vaccines have become a way of life, both due to declining effectiveness of the original vaccines especially in older adults (2), and the rapid mutation rate of SARS-CoV-2 (3). Clinical data for the new Pfizer/BioNTech booster vaccine showed superior effectiveness in eliciting an immune response against Omicron BA.1 compared to the original vaccine. Previously, Moderna published interim results from an ongoing phase 2-3 clinical trial, showing that the new bivalent booster vaccine elicited a superior neutralizing antibody response against Omicron, compared to its original COVID-19 vaccine (4).

Continue reading “mRNA Vaccine Manufacturing: Responding Effectively to a Global Pandemic”

Onward with Online Learning!

Posted on by Riley Bell

National Online Learning Day is celebrated annually on September 15, and although it was only created in 2016, it’s a growing “day”. This day highlights students of all ages who have the ability to learn anywhere, anytime, and thrive wherever their technology and imagination take them.

Technology in the past decade has completely transformed and built bridges in education. Even before the pandemic, online learning was growing and being adopted. As we entered the COVID-19 pandemic, educational institutions were forced to think digitally, and our viewpoint of online education shifted from “option” to “necessity”.

Whether you’re enrolled in a virtual course, working from home, or sitting in on a virtual conference, nearly all of us, at some compacity, take part in online learning—and it’s here to stay! The ability to learn online will continue to provide people with new resources and support for many years to come. Let’s dive into some advantages of online learning and discover helpful resources to thrive online.

Continue reading “Onward with Online Learning!”

A Virus Makes a Comeback: Emerging Poliovirus Transmission in the West

Posted on by Michele Arduengo

In 1921, at age 39, Franklin D. Roosevelt, the man who would later be elected the 32nd president of the United States, was diagnosed with polio (poliomyelitis). His symptoms included fever, gastrointestinal issues, numbness, and leg and facial paralysis. The disease left him paralyzed from the waist down, relying on a wheelchair and leg braces to walk.

The paralysis from poliovirus infection affected the involuntary muscles that allow breathing, and iron lungs were used to keep patients breathing until they cleared the infection.
The paralysis from poliovirus infection affected the involuntary muscles that allow breathing, and iron lungs were used to keep patients breathing until they cleared the infection.

At the height of the polio epidemic in 1952, more than 3,000 people died of polio in the United States, and 20,000 more people suffered paralysis. Pictures of the era show children in special hospital wards, inside ominous-looking iron lungs, while “recovered” children played on the grounds of hospitals wearing leg braces.

In 1938, Roosevelt founded the March of Dimes, which funded the development of the Salk polio vaccine. Two years after the introduction of the Salk vaccine in 1955, polio cases in the US dropped by 90%. In fact, sustained polio transmission has been absent from the US for nearly 40 years; according to the CDC, the last case of wild poliovirus in the US occurred in 1979.

Continue reading “A Virus Makes a Comeback: Emerging Poliovirus Transmission in the West”